Evidence map›Paper›PMID 32313181›Full record

ReviewBone marrow transplantation2020

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati.

Adriana Balduzzi, Erica Brivio, Attilio Rovelli, Carmelo Rizzari, Serena Gasperini, Maria Luisa Melzi, Valentino Conter, Andrea Biondi

Open access · bronzeAbstract readReview
In one paragraph

Review in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 5 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 5 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Adriana BalduzziClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy. abalduzzi@fondazionembbm.it.ORCID http://orcid.org/0000-0002-5879-0610
Erica BrivioClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Attilio RovelliClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Carmelo RizzariClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Serena GasperiniClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Maria Luisa MelziClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Valentino ConterClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
Andrea BiondiClinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.
University of Milano-Bicocca · ITFondazione Lanza · ITPrincess Máxima Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Italy is the second exposed country worldwide, after China, and Lombardia is the most affected region in Italy, with more than half of the national cases, with 13% of whom being healthcare professionals. The Clinica Pediatrica Università degli Studi di Milano Bicocca is a general pediatric and hematology oncology and transplant center embedded within the designated COVID-19 general Hospital San Gerardo in Monza, located in Lombardia, Italy. Preventive and control measures specifically undertaken to cope with the emergency within hemato-oncology, transplant, and outpatient unit in the pediatric department have been described. Preliminary COVID-19 experiences with the first Italian pediatric hemato-oncology patients are reported. The few available data regarding pediatrics and specifically hemato-oncological patients are discussed. The purpose of this report is to share pediatric hemato-oncology issues encountered in the first few weeks of the COVID-19 outbreak in Italy and to alert healthcare professionals worldwide to be prepared accordingly.

Indexed as

AdolescentAdultAgedAged, 80 and overBetacoronavirusChildChild, PreschoolCoronavirus InfectionsCOVID-19FemaleHematologyHospitalsHumansInfantInfant, NewbornInfection Control

Identifiers

PMID32313181
PMCPMC7167532
OpenAlexW3014307896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.